1. Home
  2. INAB vs CMLS Comparison

INAB vs CMLS Comparison

Compare INAB & CMLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • CMLS
  • Stock Information
  • Founded
  • INAB 2016
  • CMLS 2002
  • Country
  • INAB United States
  • CMLS United States
  • Employees
  • INAB N/A
  • CMLS N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • CMLS Broadcasting
  • Sector
  • INAB Health Care
  • CMLS Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • CMLS Nasdaq
  • Market Cap
  • INAB 23.5M
  • CMLS 21.5M
  • IPO Year
  • INAB 2021
  • CMLS 1998
  • Fundamental
  • Price
  • INAB $0.36
  • CMLS $0.71
  • Analyst Decision
  • INAB Strong Buy
  • CMLS Hold
  • Analyst Count
  • INAB 3
  • CMLS 2
  • Target Price
  • INAB $7.75
  • CMLS N/A
  • AVG Volume (30 Days)
  • INAB 2.7M
  • CMLS 67.4K
  • Earning Date
  • INAB 11-12-2024
  • CMLS 11-01-2024
  • Dividend Yield
  • INAB N/A
  • CMLS N/A
  • EPS Growth
  • INAB N/A
  • CMLS N/A
  • EPS
  • INAB N/A
  • CMLS N/A
  • Revenue
  • INAB N/A
  • CMLS $829,801,000.00
  • Revenue This Year
  • INAB N/A
  • CMLS N/A
  • Revenue Next Year
  • INAB N/A
  • CMLS N/A
  • P/E Ratio
  • INAB N/A
  • CMLS N/A
  • Revenue Growth
  • INAB N/A
  • CMLS N/A
  • 52 Week Low
  • INAB $0.22
  • CMLS $0.70
  • 52 Week High
  • INAB $2.48
  • CMLS $5.51
  • Technical
  • Relative Strength Index (RSI)
  • INAB 50.42
  • CMLS 19.31
  • Support Level
  • INAB $0.31
  • CMLS $0.70
  • Resistance Level
  • INAB $0.37
  • CMLS $0.90
  • Average True Range (ATR)
  • INAB 0.04
  • CMLS 0.08
  • MACD
  • INAB 0.01
  • CMLS -0.02
  • Stochastic Oscillator
  • INAB 38.51
  • CMLS 3.77

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About CMLS Cumulus Media Inc.

Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people every month wherever and whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with Westwood One network and numerous digital channels. The company's revenue is derived mainly from the sale of local, regional, and national advertising which is broadcast on its radio stations.

Share on Social Networks: